Zycortal for Dogs is a veterinary prescription medicine used to treat Addison’s disease (hypoadrenocorticism) in dogs. This injectable suspension is designed to help maintain electrolyte balance and prevent the life-threatening symptoms associated with this condition. It contains desoxycortone pivalate (DOCP), a synthetic mineralocorticoid that supports adrenal function by regulating sodium, potassium, and water levels in the body.
Addison’s disease occurs when a dog’s adrenal glands do not produce enough corticosteroid hormones, which are essential for various physiological functions. Without proper treatment, affected dogs may experience lethargy, vomiting, diarrhoea, dehydration, and in severe cases, collapse. Zycortal is used in combination with glucocorticoid therapy to provide long-term management of the condition, helping to stabilise a dog’s health and improve their quality of life.
How Zycortal Works
Zycortal contains desoxycortone pivalate (DOCP), which mimics the action of natural mineralocorticoid hormones that are normally produced by the adrenal glands. These hormones play a crucial role in maintaining the balance of electrolytes and fluids in the body. When a dog has Addison’s disease, their body fails to produce sufficient levels of aldosterone, a hormone responsible for regulating sodium and potassium levels. This imbalance can lead to serious complications, including dehydration, low blood pressure, and shock.
Once administered by a veterinarian as a subcutaneous injection, Zycortal helps to normalise sodium and potassium levels, reducing the risk of dangerous fluctuations. The active ingredient works over an extended period, typically requiring re-administration every 25 to 30 days. Since Zycortal only replaces mineralocorticoid function, dogs undergoing treatment will also need additional glucocorticoid therapy, such as prednisolone, to replace the deficient cortisol levels.
VETERINARY PRESCRIPTION REQUIRED.
